The new data could slow Iressa's path to market, says Catherine Arnold, an analyst at Sanford C.
Catherine Arnold, the pharmaceuticals analyst at Credit Suisse First Boston, estimates an 80% chance that Lilly will prevail.
Nevertheless, in a note this morning, Catherine Arnold of Sanford C.
Bernstein pharmaceuticals analyst Catherine Arnold pointed out that patients taking the 80-mg pills in clinical trials were already being switched to lower doses.
"We think it would be pretty risky for Apotex to launch in advance of this decision, " says Catherine Arnold, European pharmaceuticals analyst for Sanford Bernstein.
In her note to investors, Catherine Arnold of Credit Suisse speculates that Democrats in the house could favor "more draconian" measures than the Enzi-Kennedy bill.
"Merck does not have a pipeline significant enough to offset these losses, " wrote Catherine Arnold, an analyst at Credit Suisse First Boston, in a note to investors.
But Catherine Arnold of Credit Suisse First Boston says the study seems designed to play to Zyprexa's strengths, as patients will be switched off before weight gain or diabetes can develop.
In another note to investors, Catherine Arnold of Credit Suisse First Boston wrote that most investors expected Merck to win both cases because both men were at risk for heart attack without Vioxx.
In a note to investors, Catherine Arnold at Credit Suisse First Boston estimated that 25% to 35% of Vytorin and Zetia use is in patients who haven't been given other cholesterol drugs first.
But that strategy can run into problems: Catherine Arnold at Credit Suisse First Boston wrote in a note to investors this morning that there is a good chance Plavix will run into problems with the Federal Trade Commission.
Within a few years, I released a book, Lives Charmed, which featured juicy interviews with Leeza Gibbons, Arnold Palmer, Catherine Oxenberg, Paul Williams, and Woody Harrelson.
FORBES: From Dropout to Six-Figure "Book Mama": The Un-Schooling of Linda Sivertsen
应用推荐